All
RSSArticles
-
FDA Actions
-
Rasagiline and Parkinson's disease
-
CDC issues new vaccine recommendations
-
Use of SSRIs during pregnancy
-
Internal Medicine Alert - Full October 15, 2010 Issue in PDF
-
Pharmacology Watch
The World Health Organization (WHO) has issued a global alert and response regarding the use of antivirals for pandemic H1N1 flu, reiterating that antivirals should be used to prevent severe illness and death in children and adults. -
Clinical Briefs By Louis Kuritzky, MD
FDA-approved pharmacologic treatments for fibromyalgia (FIB) include duloxetine, milnacipran, and pregabalin. Although each of these agents has shown both statistically significant and clinically relevant impact, few patients are relieved of all problematic symptoms. Hence, additional treatment paths for FIB are sought. -
Ulipristal Acetate Tablets (Ella™)
A new emergency contraceptive has been approved by the FDA that is effective up to 5 days after unprotected intercourse. Ulipristal acetate is a selective progesterone receptor modulator with partial agonist and partial antagonistic effects. It is licensed from Laboratoire HRA Pharma in France and marketed by Watson Pharma as Ella™. -
Calcium Can Break Your Heart
Calcium supplementation without vitamin D supplementation is associated with an increased risk of myocardial infarction. -
Are Low HDL Levels Prognostically Important in Statin-treated Patients?
HDL-cholesterol concentrations are not predictive of residual vascular risk among patients treated with potent statin therapy who have attained very low concentrations of LDL-cholesterol.